A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease

American Journal of Hematology

Volumn 91, Issue 12, 2016, Pages 1181-1184

  Mekontso Dessap, Armand ^a,b   Pirenne, France ^c,d   Razazi, Keyvan ^a,b   Moutereau, Stéphane ^a   Abid, Shariq ^a   Brun Buisson, Christian ^a,b   Maitre, Bernard ^a   Michel, Marc ^a   Galacteros, Frederic ^a,d   Bartolucci, Pablo ^a,d   Habibi, Anoosha ^a,d  

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^d INSERM U955   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; HEMOGLOBIN; HEMOGLOBIN A; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION REACTION; CONTROLLED STUDY; DELAYED HEMOLYTIC TRANSFUSION REACTION; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; ELECTROPHORESIS; ERYTHROCYTE TRANSFUSION; FRANCE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NOMOGRAM; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; SERUM; SICKLE CELL ANEMIA; ADVERSE EFFECTS; BLOOD; COMPLICATION; FEMALE; MALE; TIME FACTOR; TRANSFUSION REACTION;

ADULT; ANEMIA, SICKLE CELL; BILIRUBIN; ERYTHROCYTE TRANSFUSION; FEMALE; FRANCE; HEMOGLOBIN A; HEMOLYSIS; HUMANS; L-LACTATE DEHYDROGENASE; MALE; NOMOGRAMS; TIME FACTORS; TRANSFUSION REACTION;

EID: 84992672482     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24537     Document Type: Article

References (24)

1. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 2010;376:2018–2031.
2. Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: Summary of the 2014 evidence-based report by expert panel members. JAMA 2014;312:1033–1048.
3. Habibi A, Arlet J-B, Stankovic K, et al. French guidelines for the management of adult sickle cell disease: 2015 update. Rev Médecine Interne Fondée Par Société Natl Francaise Méd Interne 2015;36:5S3–84.
4. Hendrickson JE, Desmarets M, Deshpande SS, et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion (Paris) 2006;46:1526–1236.
5. Fasano RM, Booth GS, Miles M, et al. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease. Br J Haematol 2015;168:291–300.
6. de Prost N, Sasanelli M, Deux J, et al. Positron emission tomography with 18F-fluorodeoxyglucose in patients with sickle cell acute chest syndrome. Med Baltim 2015;94:e821.
7. Petz LD, Calhoun L, Shulman IA, et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion (Paris) 1997;37:382–392.
8. Habibi A, Mekontso-Dessap A, Guillaud C, et al. Delayed hemolytic transfusion reaction in adult sickle-cell disease: Presentations, outcomes, and treatments of 99 referral center episodes. Am J Hematol 2016. doi:10.1002/ajh.24460.
9. Chadebech P, Habibi A, Nzouakou R, et al. Delayed hemolytic transfusion reaction in sickle cell disease patients: Evidence of an emerging syndrome with suicidal red blood cell death. Transfusion (Paris) 2009;49:1785–1792.
10. Vidler JB, Gardner K, Amenyah K, et al. Delayed haemolytic transfusion reaction in adults with sickle cell disease: A 5-year experience. Br J Haematol 2015;169:746–753.
11. Gardner K, Hoppe C, Mijovic A, Thein SL. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease. Br J Haematol 2015;170:745–756.
12. de Montalembert M, Dumont MD, Heilbronner C, et al. Delayed hemolytic transfusion reaction in children with sickle cell disease. Haematologica 2011;96:801–807.
13. Bartolucci P, El Murr T, Roudot-Thoraval F, et al. A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults. Blood 2009;114:3742–3747.
14. Mekontso Dessap A, Deux J, Habibi A, et al. Lung imaging during acute chest syndrome in sickle cell disease: Computed tomography patterns and diagnostic accuracy of bedside chest radiograph. Thorax 2014;69:144–151.
15. Robin X, Turck N, Hainard A, et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform 2011;12:77.
16. Weaver B, Wuensch KL. SPSS and SAS programs for comparing Pearson correlations and OLS regression coefficients. Behav Res Methods 2013;45:880–895.
17. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289–300.
18. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5–11.
19. King KE, Shirey RS, Lankiewicz MW, et al. Delayed hemolytic transfusion reactions in sickle cell disease: Simultaneous destruction of recipients' red cells. Transfusion (Paris) 1997;37:376–381.
20. Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617–1621.
21. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion (Paris) 2002;42:37–43.
22. Higgins JM, Sloan SR. Stochastic modeling of human RBC alloimmunization: Evidence for a distinct population of immunologic responders. Blood 2008;112:2546–2553.
23. Nickel RS, Horan JT, Fasano RM, et al. Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion: RBC alloimmunization in SCD. Am J Hematol 2015;90:1135–1141.
24. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: Pathophysiology, risk factors, and transfusion management. Blood 2012;120:528–537.